Cargando…

A qualitative transcriptional signature for the early diagnosis of colorectal cancer

Currently, using biopsy specimens for the early diagnosis of colorectal cancer (CRC) is not entirely reliable due to insufficient sampling amount and inaccurate sampling location. Thus, it is necessary to develop a signature that can accurately identify patients with CRC under these clinical scenari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Qingzhou, Zeng, Qiuhong, Yan, Haidan, Xie, Jiajing, Cheng, Jun, Ao, Lu, He, Jun, Zhao, Wenyuan, Chen, Kui, Guo, You, Guan, Guoxian, Guo, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778657/ https://www.ncbi.nlm.nih.gov/pubmed/31335996 http://dx.doi.org/10.1111/cas.14137

Ejemplares similares

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
por: Guan, Qingzhou, et al.
Publicado: (2021)

Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy
por: He, Jun, et al.
Publicado: (2019)

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2018)

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer
por: Yan, Haidan, et al.
Publicado: (2019)

Two novel qualitative transcriptional signatures robustly applicable to non‐research‐oriented colorectal cancer samples with low‐quality RNA
por: Cheng, Jun, et al.
Publicado: (2021)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

The Effects of Age, Cigarette Smoking, Sex, and Race on the Qualitative Characteristics of Lung Transcriptome
por: Guan, Qingzhou, et al.
Publicado: (2020)

Robust transcriptional signatures for low-input RNA samples based on relative expression orderings
por: Liu, Huaping, et al.
Publicado: (2017)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection
por: Li, Yawei, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples
por: Chen, Rou, et al.
Publicado: (2016)

Identification of Common and Subtype-Specific Mutated Sub-Pathways for a Cancer
por: Yan, Haidan, et al.
Publicado: (2019)

Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis
por: Yan, Haidan, et al.
Publicado: (2017)

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer
por: Cheng, Jun, et al.
Publicado: (2020)

Identification of population-level differentially expressed genes in one-phenotype data
por: Xie, Jiajing, et al.
Publicado: (2020)

Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers
por: Guo, You, et al.
Publicado: (2016)

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues
por: Tong, Mengsha, et al.
Publicado: (2015)

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms
por: Guan, Qingzhou, et al.
Publicado: (2016)

Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes
por: Cai, Hao, et al.
Publicado: (2019)

A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer
por: Fu, Yelin, et al.
Publicado: (2019)

Shared liver-like transcriptional characteristics in liver metastases and corresponding primary colorectal tumors
por: Cheng, Jun, et al.
Publicado: (2018)

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
por: Ao, Lu, et al.
Publicado: (2015)

Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites
por: Cheng, Jun, et al.
Publicado: (2017)

Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis
por: Sun, Yulin, et al.
Publicado: (2022)

A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon Cancer
por: You, Tianyi, et al.
Publicado: (2020)

Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues
por: Yan, Haidan, et al.
Publicado: (2017)

Identification of Genes Universally Differentially Expressed in Gastric Cancer
por: Shi, Yidan, et al.
Publicado: (2021)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
por: Chen, Rou, et al.
Publicado: (2019)

Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning
por: He, Jun, et al.
Publicado: (2017)

A rank-based algorithm of differential expression analysis for small cell line data with statistical control
por: Li, Xiangyu, et al.
Publicado: (2017)

Delineation of colorectal cancer ligand-receptor interactions and their roles in the tumor microenvironment and prognosis
por: Lin, Hexin, et al.
Publicado: (2021)

A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy
por: Li, Xiang, et al.
Publicado: (2020)

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)

The prognostic significance of different proportion of signet-ring cells of colorectal carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources
por: Zhao, Wenyuan, et al.
Publicado: (2016)

CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses
por: Lin, Hexin, et al.
Publicado: (2020)

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jjjsv94m6dqoilvst332dgbtbg